The present invention relates to a method for producing cartilaginous tissue by means of selection of and sampling from chondrocytes or spheroids and the use thereof as pharmaceutical composition, drug or transplant. The invention specifically relates to markers for identifying suitable chondrocytes for producing cartilaginous tissue, in particular for the purpose of transplantation.